Characterization and Clinical Utility of BRAF(V600) Mutation Detection Using Cell-Free DNA in Patients with Advanced Melanoma

SIMPLE SUMMARY: The choice of cancer drug(s) for the treatment of advanced melanoma is based on the types of gene alterations that are present in the patient’s tumor(s). Sometimes, the tumor sample that is obtained from surgery may be degraded, and the test does not provide a reliable result, leadin...

Descripción completa

Detalles Bibliográficos
Autores principales: Rutkowski, Piotr, Pauwels, Patrick, Kerger, Joseph, Jacobs, Bart, Maertens, Geert, Gadeyne, Valerie, Thielemans, Anne, de Backer, Katrien, Neyns, Bart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305047/
https://www.ncbi.nlm.nih.gov/pubmed/34298804
http://dx.doi.org/10.3390/cancers13143591

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305047/
https://www.ncbi.nlm.nih.gov/pubmed/34298804
http://dx.doi.org/10.3390/cancers13143591

Ejemplares similares